Patients using drugs
Conditions
Interventions
Group 1: Patients receiving drug treatment will be documented during regular pharmacological ward rounds.
Sponsors
Institut für Experimentelle und Klinische Pharmakologie, UKSH, Campus Kiel
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Drug use
Exclusion criteria
Exclusion criteria: Suspected misdocumentation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Feasibility of data collection (i.e., check for sufficiently complete documentation of all patients seen during the ward rounds) | — |
Secondary
| Measure | Time frame |
|---|---|
| Prescription rate, grouped for on-label and off-label and palliative or curative treatment Rate of known DDI in prescriptions Rate of inadequate dosing in renal disease Assessment of clinical significance of the DDI findings Subjective efficacy of medication Mean treatment duration Rate of suspected ADR Documentation of efficacy/safety of other measures not regulated by German drug law Documentation of time spent for clinical-pharmacological rounds | — |
Countries
Germany
Contacts
Public ContactRuwen Böhm
Institut für Experimentelle und Klinische Pharmakologie, UKSH, Campus Kiel
Outcome results
None listed